Treatment of ovarian estrogen dependent conditions
US5681817A · kind A · utility
61Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 1994 |
| Grant date | Oct 28, 1997 |
| Priority date | — |
| Expiry date | Feb 4, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating an ovarian estrogen dependent condition such as endometriosis, uterine leiomyomata, PMS or DUB involving the administration of gonadotropin releasing hormone analog and the administration of antiprogestin, which will provide a therapeutic method for long term treatment without rapid loss of bone density, as occurs using GnRH analogs alone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.